Literature DB >> 6472021

Intralabyrinthine schwannoma.

D M Vernick, M D Graham, K D McClatchey.   

Abstract

The diagnosis of intralabyrinthine schwannoma has been made either accidentally at the time of surgery or at postmortem examination. Brain stem evoked response audiometry and computerized tomography do not add to our ability to make this diagnosis clinically. A case is presented of an intralabyrinthine schwannoma found at the time of transmastoid labyrinthectomy. The literature is reviewed and a composite clinical picture is presented.

Entities:  

Mesh:

Year:  1984        PMID: 6472021     DOI: 10.1288/00005537-198409000-00020

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  6 in total

1.  Intralabyrinthine schwannomas: imaging diagnosis and classification.

Authors:  K L Salzman; A M Childs; H C Davidson; R J Kennedy; C Shelton; H R Harnsberger
Journal:  AJNR Am J Neuroradiol       Date:  2011-12-08       Impact factor: 3.825

2.  A petrous bone destructive acoustic neurinoma: a tumor of far-lateral origin?

Authors:  T Sekiya; K Itoh; K Asano; S Suzuki
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

Review 3.  Meta-analysis on the clinical outcomes in patients with intralabyrinthine schwannomas: conservative management vs. microsurgery.

Authors:  Émilie Gosselin; Anastasios Maniakas; Issam Saliba
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-02-12       Impact factor: 2.503

4.  Intralabyrinthine schwannoma shown by magnetic resonance imaging.

Authors:  S R Saeed; A R Birzgalis; R T Ramsden
Journal:  Neuroradiology       Date:  1994       Impact factor: 2.804

5.  Progressive hearing loss in intracochlear schwannoma.

Authors:  Tadashi Nishimura; Hiroshi Hosoi
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-10-12       Impact factor: 2.503

6.  Histopathologic Evaluation of Intralabyrinthine Schwannoma.

Authors:  Michael Bagattini; Alicia M Quesnel; Christof Röösli
Journal:  Audiol Neurootol       Date:  2020-12-22       Impact factor: 1.854

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.